COMMUNIQUÉS West-GlobeNewswire

Syndax Announces Compelling Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr) Data Accepted for Presentation at ASH 2025
03/11/2025
– 12 revumenib and 11 axatilimab abstracts accepted, including 6 oral presentations, underscoring Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase compelling results in [...]
Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025
03/11/2025
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the Company will host an in- [...]
Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeting
03/11/2025
CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, regardless of FLT3 mutational status ~30% CRc rate observed at clinically [...]
Kura Oncology and Kyowa Kirin Announce Presentations of Ziftomenib Ven/Aza Combination Data in Frontline and Relapsed/Refractory NPM1-m or KMT2A-r Acute Myeloid Leukemia at 2025 ASH Annual Meeting
03/11/2025
– Data to be featured in two oral presentations on December 8, 2025 – – Broad development program assesses ziftomenib across diverse AML segments and treatment paradigms to inform appropriate use – SAN DIEGO and TOKYO, [...]
MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule
03/11/2025
Company is Well Positioned to Continue to Compete and Grow MARIETTA, Ga., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today commented on the Centers for Medicare and [...]
Cellectis présentera de nouvelles avancées sur éti-cel lors du congrès annuel de l’ASH 2025
03/11/2025
Les données préliminaires récemment présentées pour eti-cel (UCART20x22) montrent un taux de réponse global (ORR) de 86 % et un taux de réponse complète (CR) de 57 % (n=7), soulignant le potentiel de cette approche pour [...]
Cellectis to Present a Development Update for eti-cel at ASH 2025
03/11/2025
Preliminary data recently shared for eti-cel (UCART20x22) show an 86% ORR and a 57% CR rate (n=7), underscoring its potential to improve outcomes in r/r NHL Preclinical data demonstrated that combining eti-cel with low- [...]
Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting
03/11/2025
Ongoing Phase 1 APOLLO study investigating MT-601 in patients with relapsed B cell lymphomas showed encouraging preliminary efficacy data MT-601 demonstrated robust safety profile with no dose limiting toxicities (DLTs [...]
Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines Describing the Mechanism of Action and Potency Assay for its Investigational Cell Therapy, Deramiocel
03/11/2025
–Publication highlights Deramiocel’s anti-fibrotic activity and describes a validated potency assay supporting quality control and product consistency in late-stage development– SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE [...]
Global Congress of Polish Medical Communities “Save a Life” 2025 – A Worldwide Mission to Advance Life-Saving Expertise
03/11/2025
International collaboration, medical excellence, and integration of Polish medical professionals worldwide WARSAW, Poland, Nov. 03, 2025 (GLOBE NEWSWIRE) -- On 21–22 November 2025 , the Warsaw Medical University ( [...]
Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
03/11/2025
At 24 months, the target lesion primary patency (TLPP) 1 was 41.7% At 24 months, the access circuit primary patency (ACPP) 2 was 25.7% SOUTH JORDAN, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. ( [...]
Syncx Announces Strategic Partnership with Fetch Data and Assist ATS, Creating the First Fully Connected Healthcare MSP, VMS, Sourcing and Staffing Operating System
03/11/2025
ATLANTA, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Syncx, the healthcare workforce-management platform redefining how health systems manage locum tenens, float pools, contingent and permanent labor, today announced a three-way [...]
Mira Aesthetic Cosmetic Surgery Center Supports Local Athletics with Charitable Donation to Corona del Mar High School
03/11/2025
NEWPORT BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Mira Aesthetic Cosmetic Surgery Center , led by board-certified surgeon Dr. Sid Mirrafatti, today announced a charitable contribution to Corona del Mar High [...]
Scilex Holding Company Announces the Sponsorship of Dream Bowl 2026 and Set a Record Date of November 14, 2025 for Its Shareholders to Receive Dream Bowl 2026 Meme Coin Distributed by DataVault AI
03/11/2025
PALO ALTO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Baylor Genetics Applauds Medi-Cal's Decision to Cover Whole Genome Sequencing
03/11/2025
Decision brings total number of Medicaid programs offering WGS coverage to 30 states and Puerto Rico HOUSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics , a leading clinical diagnostic laboratory at the forefront [...]
Almafit Announces Strategic Partnership with Renowned Pilates Expert Lisa Hubbard
03/11/2025
Collaboration empowers midlife Pilates enthusiasts with innovative equipment and expert guidance. Duluth, Georgia, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Almafit , a developer of premium Pilates reformers, today announced a [...]
Actimed Therapeutics Further Expands Intellectual Property Portfolio for Lead Compound with New Composition of Matter Patent in Japan
03/11/2025
Patent expands IP protection for S-pindolol benzoate (ACM-001.1), reinforcing the global IP position of Actimed with granted patents in all key markets London, UK – 3 November 2025. Actimed Therapeutics Ltd (“Actimed” [...]
CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610)
03/11/2025
CMS adopts Final Rule for 2026 Physician Fee Schedule in line with proposed rule for CPT code 97610 2026 rates for physician offices, home visits, long-term care, and hospitals are in line with the proposed rule and [...]
SARMs For Bulking And Cutting Stacks Alternative 2025: Crazy Bulk Launch Legal SARMs For Muscle Growth, Strength & Endurance Supplement.
03/11/2025
CrazyBulk’s Line of Legal, Safe, and Best SARMs Alternative supplements are crafted to help torch fat, skyrocket testosterone, and improve muscle growth, strength, and repair. NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE [...]

Pages